Previous 10 | Next 10 |
Achieves fourth quarter revenue growth of 9% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 11% reported and 10% organic Solid growth supported by continued benefits from IDEXX execution drivers, including 11% year-over-year expansion of IDEXX's global prem...
Kimball Electronics Inc. (KE) is expected to report $0.37 for Q2 2024 Sturgis Bancorp Inc (STBI) is expected to report for Q4 2023 Simon Property Group Inc. (SPG) is expected to report $3.34 for Q4 2023 Cabot Corporation (CBT) is expected to report $1.49 for Q1 2024 ChampionX Corp...
2024-02-02 13:52:47 ET More on IDEXX Laboratories IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified IDEXX: Future Seems Bright, But It's A 'Hold' For Me Piper Sandler downgrades Idexx to neutral, cites macro headwinds Seeking Alpha’s Quant ...
2024-02-02 09:41:25 ET Major earnings expected before the bell on Monday include: Air Products and Chemicals ( APD ) Caterpillar ( CAT ) McDonald's ( MCD ) ON Semiconductor ( ON ) Tyson Foods ( TSN ) Read the full article on Seeking Alpha ...
2024-01-30 16:08:34 ET More on IDEXX Laboratories IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified IDEXX: Future Seems Bright, But It's A 'Hold' For Me IDEXX: A Realistic Path To 12-14% Annual Returns Seeking Alpha’s Quant Rating on IDEXX ...
2024-01-24 10:36:22 ET More on Markets 5 stocks to watch on Wednesday: AT&T, Tesla, Walgreens and more Netflix is forcing Wall Street to play catch up as stock continues to rocket AT&T slides as weak 2024 earnings forecast, increased spending spook investors ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens. The Company will conduct an analyst conference call beginning at 8:30...
2024-01-22 11:29:07 ET More on S&P 500 Index: S&P 500 Sets New Record High As Investors Potentially Shift Focus To Q2 2024 Market Rally Met With Outflows S&P 500: The 'Pump' Is Underway - Watch Out For The 'Dump' S&P won't get the helping hand...
2024-01-20 10:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A drastic shift in inv...
2024-01-16 11:00:00 ET Summary IDEXX Laboratories has outperformed the broader market and continues to show strong growth in its diagnostic products and services for pets. The company is shifting towards recurring revenue streams, which improves sales visibility and customer reten...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology, will part...
Wednesday, IDEXX Laboratories Inc (NASDAQ:IDXX) reported first-quarter adjusted EPS of $2.81, up 10% Y/Y, beating the consensus...